Phibro Animal Health Corporation (PAHC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 316.47M USD | Liabilities, Current |
| Cash and equivalents | 61.42M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 238.79M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 534.88M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $316.47M | $61.42M | (m) | $238.79M | $534.88M | (m) |
| 2026-03-31 | (m) | $281.87M | $54.93M | (m) | $221.55M | $539.70M | (m) |
| 2025-12-31 | (m) | $282.37M | $55.49M | (m) | $215.87M | $517.35M | (m) |
| 2025-09-30 | (m) | $270.14M | $72.77M | (m) | $217.90M | $471.77M | (m) |
| 2025-06-30 | (m) | $293.47M | $68.04M | (m) | $227.98M | $444.43M | (m) |
| 2025-03-31 | (m) | $266.48M | $60.35M | (m) | $197.52M | $448.39M | (m) |
| 2024-12-31 | (m) | $233.25M | $67.07M | (m) | $191.79M | $427.22M | (m) |
| 2024-09-30 | (m) | $176.89M | $51.84M | (m) | $160.78M | $272.56M | (m) |
| 2024-06-30 | (m) | $204.15M | $70.61M | (m) | $169.45M | $265.91M | (m) |
| 2024-03-31 | (m) | $189.07M | $50.23M | (m) | $161.09M | $282.29M | (m) |
| 2023-12-31 | (m) | $187.74M | $32.97M | (m) | $150.63M | $286.68M | (m) |
| 2023-09-30 | (m) | $172.35M | $43.15M | (m) | $149.23M | $279.15M | (m) |
| 2023-06-30 | (m) | $176.00M | $41.28M | (m) | $163.48M | $277.57M | (m) |
| 2023-03-31 | (m) | $165.31M | $37.24M | (m) | $152.74M | $292.83M | (m) |
| 2022-12-31 | (m) | $167.57M | $68.42M | (m) | $151.83M | $288.98M | (m) |
| 2022-09-30 | (m) | $172.50M | $76.28M | (m) | $142.73M | $280.84M | (m) |
| 2022-06-30 | (m) | $190.83M | $74.25M | (m) | $166.54M | $259.16M | (m) |
| 2022-03-31 | (m) | $187.10M | $70.75M | (m) | $156.56M | $249.91M | (m) |
| 2021-12-31 | (m) | $166.63M | $63.38M | (m) | $142.50M | $230.78M | (m) |
| 2021-09-30 | (m) | $152.59M | $41.17M | (m) | $140.64M | $221.31M | (m) |
| 2021-06-30 | (m) | $164.12M | $50.21M | (m) | $146.85M | $216.31M | (m) |
| 2021-03-31 | (m) | $168.89M | $49.10M | (m) | $135.56M | $206.26M | (m) |
| 2020-12-31 | (m) | $166.90M | $34.53M | (m) | $126.03M | $213.33M | (m) |
| 2020-09-30 | (m) | $160.95M | $30.97M | (m) | $125.46M | $205.85M | (m) |
| 2020-06-30 | (m) | $157.24M | $36.34M | (m) | $126.52M | $196.66M | (m) |
| 2020-03-31 | (m) | $161.23M | $26.75M | (m) | $151.56M | $177.29M | (m) |
| 2019-12-31 | (m) | $147.06M | $26.18M | (m) | $147.44M | $193.51M | (m) |
| 2019-09-30 | (m) | $141.97M | $54.89M | (m) | $145.44M | $203.87M | (m) |
| 2019-06-30 | (m) | $154.23M | $57.57M | (m) | $159.02M | $198.32M | (m) |
| 2019-03-31 | (m) | $132.54M | $35.88M | (m) | $152.97M | $189.88M | (m) |
| 2018-12-31 | (m) | $135.83M | $31.34M | (m) | $144.05M | $193.10M | (m) |
| 2018-09-30 | (m) | $128.73M | $25.86M | (m) | $134.81M | $185.79M | (m) |
| 2018-07-01 | (m) | (m) | $29.17M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $143.22M | $29.17M | (m) | $135.74M | $178.17M | (m) |
| 2018-03-31 | (m) | $128.54M | $30.55M | (m) | $127.04M | $184.48M | (m) |
| 2017-12-31 | (m) | $127.24M | $40.19M | (m) | $132.24M | $173.61M | (m) |
| 2017-09-30 | (m) | $121.11M | $62.10M | (m) | $136.34M | $170.93M | (m) |
| 2017-06-30 | (m) | $115.80M | $56.08M | (m) | $125.85M | $161.23M | (m) |
| 2017-03-31 | (m) | $106.30M | $49.31M | (m) | $113.13M | $163.83M | (m) |
| 2016-12-31 | (m) | $103.33M | $39.22M | (m) | $124.13M | $158.82M | (m) |
| 2016-09-30 | (m) | $101.34M | $37.41M | (m) | $119.61M | $162.64M | (m) |
| 2016-06-30 | (m) | $108.67M | $33.60M | (m) | $123.79M | $167.69M | (m) |
| 2016-03-31 | (m) | $99.78M | $32.23M | (m) | $116.23M | $168.29M | (m) |
| 2015-12-31 | (m) | $114.53M | $25.37M | (m) | $114.57M | $154.42M | (m) |
| 2015-09-30 | (m) | $108.33M | $31.82M | (m) | $113.71M | $147.29M | (m) |
| 2015-06-30 | (m) | $111.33M | $29.22M | (m) | $111.10M | $149.79M | (m) |
| 2015-03-31 | (m) | $105.48M | $20.80M | (m) | $115.15M | $136.37M | (m) |
| 2014-12-31 | (m) | $101.38M | $20.69M | (m) | $114.26M | $144.86M | (m) |
| 2014-09-30 | (m) | $106.79M | $19.75M | (m) | $110.76M | $146.38M | (m) |
| 2014-06-30 | (m) | $112.44M | $11.82M | (m) | $113.86M | $143.18M | (m) |
| 2014-03-31 | (m) | $115.34M | $10.98M | (m) | $107.70M | $142.80M | (m) |
| 2013-12-31 | (m) | (m) | $30.47M | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $36.85M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $115.40M | $27.37M | (m) | $99.14M | $140.03M | (m) |
| 2013-03-31 | (m) | (m) | $28.27M | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $53.90M | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $48.60M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.